Clinical evaluation is now more important than ever under EU-MDR
Insights from a Let's Talk Risk! conversation with Florian Tolkmitt
Note: this article highlights key insights gained from a conversation with Florian Tolkmitt as part of the Let’s Talk Risk! with Dr. Naveen Agarwal series on LinkedIn. Listen to the full recording of the discussion below.
Summary
Here are a few key points that emerged from our discussion:
Clinical investigations provide one type of data for clinical evaluation
Establishing thresholds for risk management and clinical evaluation continues to be a challenge
Think of clinical evaluation as a process, not simply a document for compliance
Let us dive in.
Keep reading with a 7-day free trial
Subscribe to Let's Talk Risk! to keep reading this post and get 7 days of free access to the full post archives.